Mingzhi Zhang
Chinese Academy of Sciences(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Viral-associated cancers and disorders, Chronic Lymphocytic Leukemia Research, Immune Cell Function and Interaction
Most-Cited Works
- → PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?(2017)290 cited
- → Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor(2016)246 cited
- → miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42(2011)139 cited
- → miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy(2018)131 cited
- → miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy(2018)126 cited
- → MYD88 L265P Mutation in Lymphoid Malignancies(2018)122 cited
- → A common variant near TGFBR3 is associated with primary open angle glaucoma(2015)117 cited
- → Six1 Promotes Proliferation of Pancreatic Cancer Cells via Upregulation of Cyclin D1 Expression(2013)92 cited
- → Targeting PD-L1 in non-small cell lung cancer using CAR T cells(2020)89 cited
- → Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma(2020)83 cited